A
Aurinia Pharmaceuticals
AUPH
5.60000
USD
-0.28
(-4.76%)
مفتوح الان
حجم التداول
11,400
الربح لكل سهم
0
العائد الربحي
0
P/E
-20
حجم السوق
1,003,796,637
الأخبار
العنوان: Aurinia Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.